Carregant...
Nimotuzumab plus platinum-based chemotherapy platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
Background: Palliative chemotherapy has been the mainstay treatment for patients with recurrent or metastatic nasopharyngeal carcinoma (R/M-NPC). However, little is known about the efficacy and toxicity of nimotuzumab (NTZ) – a monoclonal antibody drug targeting epidermal growth factor receptor – pl...
Guardat en:
Autors principals: | , , , , , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
SAGE Publishing
2020-09-01
|
Col·lecció: | Therapeutic Advances in Medical Oncology |
Accés en línia: | https://doi.org/10.1177/1758835920953738 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|